Literature DB >> 20696246

Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.

Smita Zaheer1, Yanghong Wu, Shailendra K Sahu, Asgar Zaheer.   

Abstract

Glia maturation factor (GMF), a primarily CNS localized protein was discovered and characterized in our laboratory. We previously demonstrated that GMF is the upstream regulator for excessive production and release of proinflammatory cytokines/chemokines in brain cells leading to the destruction of oligodendrocytes, the myelin forming cells, and neurons. We also reported that mice lacking endogenous GMF (GMF-deficient, GMF-KO) were resistant to myelin oligodendrocyte glycoprotein peptide 35-55 (MOG(35-55)) induced EAE, since immunization induced only delayed EAE with diminished severity. In the present study we show that a replication-defective adenovirus-GMF construct caused expression of GMF in CNS of GMF-KO mice and reinstated MOG(35-55) induced early and severe EAE. Our results show that MOG(35-55) immunization caused only a muted EAE and inflammation/demyelination in mice lacking endogenous GMF. The diminished incidence of EAE in GMF-KO mice was consistent with the significantly reduced expressions of cytokines/chemokines. The muted severity of EAE in GMF-KO mice was restored to full blown levels upon reintroduction of GMF using an adeno-GMF-virus (Adv-GMF) vector. Consistent with the clinical findings, histological examination of the CNS of mice with EAE revealed profound differences between wild type (Wt), GMF-KO, and GMF-KO mice with re-introduced GMF (GMF-KO+Adv-GMF). Spinal cord sections from mice with EAE were analyzed for the infiltration of mononuclear cells (inflammation) and myelin loss (demyelination). In Wt mice, 40% of spinal cord quadrants were positive for demyelination and 45% of spinal cord quadrants were positive for inflammation at the peak of EAE. Drastically reduced infiltrates (15%) and demyelination (10%) were found in GMF-KO mice that developed reduced severity of EAE. Upon GMF reintroduction in GMF-KO mice, MOG(35-55) immunization caused extensive monocytes infiltration (48%) and demyelination (46%), similar to that observed in the immunized Wt mice. The levels of cytokine/chemokine in the spinal cords of mice at three time points, corresponding to the onset, peak severity and recovery period of EAE, show a distinct pattern of very large increases in IFN-γ, TNF-α, GM-CSF and MCP-1 in Wt and GMF-KO+Adv-GMF mice compared to GMF-KO and GMF-KO+Adv-LacZ mice.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696246      PMCID: PMC2955779          DOI: 10.1016/j.nbd.2010.08.003

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

1.  Impaired motor performance and learning in glia maturation factor-knockout mice.

Authors:  Ramon Lim; Asgar Zaheer; Houdy Khosravi; John H Freeman; Hunter E Halverson; John A Wemmie; Baoli Yang
Journal:  Brain Res       Date:  2004-10-22       Impact factor: 3.252

Review 2.  Etiology and pathogenesis of multiple sclerosis.

Authors:  T L Sørensen; R M Ransohoff
Journal:  Semin Neurol       Date:  1998       Impact factor: 3.420

3.  Purification and characterization of glia maturation factor beta: a growth regulator for neurons and glia.

Authors:  R Lim; J F Miller; A Zaheer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 4.  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.

Authors:  L Steinman
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

5.  Expression of mRNAs of multiple growth factors and receptors by astrocytes and glioma cells: detection with reverse transcription-polymerase chain reaction.

Authors:  A Zaheer; W Zhong; E Y Uc; D R Moser; R Lim
Journal:  Cell Mol Neurobiol       Date:  1995-04       Impact factor: 5.046

6.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.

Authors:  B L Davidson; E D Allen; K F Kozarsky; J M Wilson; B J Roessler
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

7.  Expression of mRNAs of multiple growth factors and receptors by neuronal cell lines: detection with RT-PCR.

Authors:  A Zaheer; W Zhong; R Lim
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

8.  Molecular cloning and expression of biologically active human glia maturation factor-beta.

Authors:  R Kaplan; A Zaheer; M Jaye; R Lim
Journal:  J Neurochem       Date:  1991-08       Impact factor: 5.372

9.  Expression of glia maturation factor beta mRNA and protein in rat organs and cells.

Authors:  A Zaheer; B D Fink; R Lim
Journal:  J Neurochem       Date:  1993-03       Impact factor: 5.372

10.  Overexpression of glia maturation factor in C6 cells promotes differentiation and activates superoxide dismutase.

Authors:  R Lim; A Zaheer; J A Kraakevik; C J Darby; L W Oberley
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

View more
  8 in total

1.  Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Ramasamy Thangavel; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-03-25       Impact factor: 3.996

Review 2.  Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds.

Authors:  Sandra Chánez-Paredes; Armando Montoya-García; Michael Schnoor
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

3.  Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody.

Authors:  Smita Zaheer; Yanghong Wu; Shailendra K Sahu; Asgar Zaheer
Journal:  Brain Res       Date:  2010-12-10       Impact factor: 3.252

4.  Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+)).

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Ranan Fattal; Sagar Pattani; Evert Yang; Smita Zaheer; Donna A Santillan; Mark K Santillan; Asgar Zaheer
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

5.  Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice.

Authors:  Smita Zaheer; Ramasamy Thangavel; Yanghong Wu; Mohammad Moshahid Khan; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-10-20       Impact factor: 3.996

Review 6.  Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation.

Authors:  Junsheng Fan; Tszhei Fong; Xinjie Chen; Chuyun Chen; Peng Luo; Haiting Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-09       Impact factor: 2.570

7.  First description of enhanced expression of glia maturation factor-beta in experimental toxoplasmic encephalitis.

Authors:  Gungor Cagdas Dincel
Journal:  J Int Med Res       Date:  2017-08-04       Impact factor: 1.671

Review 8.  GMF as an Actin Network Remodeling Factor.

Authors:  Bruce L Goode; Meredith O Sweeney; Julian A Eskin
Journal:  Trends Cell Biol       Date:  2018-05-18       Impact factor: 20.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.